Robyn Goforth, PhD

Robyn Goforth, PhD
As Vice President Technology Assessment at VIC, Dr. Goforth leads technical and commercial evaluation of technologies ranging from medical devices to pharmaceuticals as well as scientific research tools and instrumentation. Dr. Goforth also serves as Chief Scientific Officer of VIC portfolio company, BiologicsMD ™

Recent Posts

Behind the Curtain: Opportunity Assessment at VIC

Ask ten people how best to assess the value of a new technology, and you’ll likely get ten different answers. Google "opportunity assessment", and you will find hundreds of different templates, worksheets, and...

FEATURED RESOURCES

News
VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics
Case Study
The Emerging Remote Workplace: Digital Best Practices for Investor Groups
Reports
VIC 2019 Annual Report
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
News
VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact
Interview
An Interview with Nichole Mercier at Washington University
White Paper
Sourcing Quality Innovation Beyond the VC Hot Zones
Case Study
Behind the Curtain: Opportunity Assessment at VIC Technology Venture Development
White Paper
New Paradigms of Life Science Investing
Interview
Behind the Curtain with Biolocity | Guiding Medical Innovations to Market
News
VIC Technology Venture Development Forms New Portfolio Company: Filtravate
White Paper
Life Science Impact Investing and the Physician Entrepreneur
From The Corner Office
SFC Fluidics Nears FDA Submission